Concepedia

Steven Zhang

SZ

Statistics

Publications

11

Citations

351

H-Index

11

Active since

2003

Affiliations

Stanford University(Current)

VA Palo Alto Health Care System

Bristol-Myers Squibb (Sweden)

Center for Innovation

Johnson & Johnson (United States)

Steven Zhang is an author at Stanford University specializing in medicine, clinical pharmacology, and oncology pharmacology.

Publications per year

2003–2025

11

Publications

11

A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia

Jean‐Luc Harousseau, Jeffrey E. Lancet, Josy Reiffers et al. · Blood · 2007 · 81 citations · Full text

Medicine, Oncology, Pharmacology +11

Cost-Minimization Analysis of Open and Endoscopic Carpal Tunnel Release

Steven Zhang, Molly Vora, Alex H. S. Harris et al. · Journal of Bone and Joint Surgery · 2016 · 47 citations

Pharmacy, Pharmacoeconomics, Surgery +17

Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia

Juraj Bies, Marek Šramko, Joanna Fares et al. · Blood · 2010 · 38 citations

Medicine, Molecular Biology, Molecular Genetics +11

Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease

Kelly K. Nichols, Eric D. Donnenfeld, Paul Karpecki et al. · European Journal of Ophthalmology · 2018 · 37 citations · Full text

Medicine, Dermatology, Ophthalmology +17

Physical and Occupational Therapy Use and Cost After Common Hand Procedures

Romil Shah, Steven Zhang, Kevin Li et al. · The Journal Of Hand Surgery · 2019 · 37 citations

Medicine, Health Sciences, Rehabilitation Medicine +9

1–5 of 11